45 Participants Needed

Micro-filament Intracranial Recording for Epilepsy

(NeuroSeizure Trial)

AP
BF
Overseen ByBirgit Frauscher, MD, PhD
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

record fast ripples with novel intracranial electrodes with micro-tetrodes to improve the identification of epileptogenic zone (EZ) and investigate the neuronal circuits underlying brain dynamics associated with epilepsy

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications, but if you are on anti-thrombotic treatment (medications that prevent blood clots), you may not be eligible to participate.

What data supports the effectiveness of the treatment Macro-micro Tetrodes, Hybrid Electrodes, Macro-micro Depth Electrodes, Tetrode-equipped Electrodes for epilepsy?

Research shows that hybrid electrodes equipped with tetrodes can successfully record brain activity in epileptic patients, providing high-quality data that helps in understanding and treating epilepsy. These electrodes have been used to isolate neuron activity more effectively than traditional methods, which is crucial for identifying seizure origins and planning surgical interventions.12345

Is the Micro-filament Intracranial Recording for Epilepsy generally safe for humans?

Research shows that intracranial electrode implantation, including micro-macroelectrodes, has a favorable safety profile with a low complication rate of 4.9%, and no permanent harm was recorded. Additionally, new thin-film electrodes have passed extensive safety tests and are FDA-cleared for human use, indicating they are safe for clinical practice.16789

How is the Micro-filament Intracranial Recording for Epilepsy treatment different from other treatments for epilepsy?

This treatment uses hybrid electrodes equipped with tetrodes, which are more effective at isolating single neuron activity compared to traditional electrodes. This allows for more precise recording of brain activity, helping to better identify the areas responsible for seizures in epilepsy patients.123610

Eligibility Criteria

This trial is for individuals with refractory epilepsy who are eligible for a special brain monitoring procedure called sEEG. It's not suitable for those with severe psychiatric issues, intense agitation during seizures, or conditions that prevent MRI scans like claustrophobia or certain implants.

Inclusion Criteria

I am eligible for a brain monitoring procedure.
My epilepsy does not improve with treatment.

Exclusion Criteria

I am not pregnant, nursing, or have severe health issues like heart, lung, kidney, or liver diseases.
Severe agitation during their crisis
Severe psychiatric disorders
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Implantation and Monitoring

Patients are implanted with novel intracerebral micro-macroelectrodes to record fast ripples and single neuron activity

1 week
In-patient monitoring

Assessment

Evaluate the efficiency of microelectrodes compared to macroelectrodes in recording fast ripples

10 days

Follow-up

Participants are monitored for safety and effectiveness after the implantation and assessment phases

4 weeks

Treatment Details

Interventions

  • Macro-micro Tetrodes
Trial Overview The study is testing new intracranial electrodes with micro-tetrodes to record 'fast ripples' in the brain. This could help better identify the epileptogenic zone and understand the neuronal circuits in epilepsy.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: micro-macroelectrodesExperimental Treatment1 Intervention
Patients will be implanted with usually the novel intracerebral micro-macroelectrodes (instead of the regular clinical macroelectrodes). The primary and secondary outcomes will then be assessed.

Macro-micro Tetrodes is already approved in European Union, United States for the following indications:

🇪🇺
Approved in European Union as Hybrid Electrodes for:
  • Epilepsy diagnosis
  • Epileptogenic zone identification
🇺🇸
Approved in United States as Macro-micro Depth Electrodes for:
  • Research use in epilepsy
  • Investigational device for EZ identification

Find a Clinic Near You

Who Is Running the Clinical Trial?

Adrien Peyrache

Lead Sponsor

Trials
1
Recruited
50+

McGill University

Lead Sponsor

Trials
421
Recruited
1,017,000+

Findings from Research

The new hybrid electrode, which combines macroelectrodes and tetrodes, was safely implanted in 28 epileptic patients without any clinical complications, demonstrating its compatibility with clinical intracranial recordings.
This hybrid design allowed for effective isolation of single neuron activity, achieving a promising single-unit yield of over 10 neurons per tetrode, and provided unique spatial information that traditional macro-contacts could not capture.
Recording local field potential and neuronal activity with tetrodes in epileptic patients.Despouy, E., Curot, J., Reddy, L., et al.[2021]
A new hybrid depth electrode (HDE) method allows for high-quality in vivo microelectrode recordings from individual neurons in patients with epilepsy, enhancing the ability to study brain activity during clinical procedures.
In a study involving six patients with medically refractory epilepsy, the HDE provided excellent recordings over 5 to 14 days, enabling detailed physiological investigations while patients remained comfortable and cooperative.
A hybrid clinical-research depth electrode for acute and chronic in vivo microelectrode recording of human brain neurons. Technical note.Howard, MA., Volkov, IO., Granner, MA., et al.[2006]
Intracerebral electrodes, which can be implanted for several days, provide a more precise localization of the epileptic focus compared to traditional scalp recordings, allowing for better mapping of the cortical epileptic network.
These electrodes not only enhance the understanding of epilepsy through high-resolution recordings but also enable direct cortical stimulation to identify critical brain areas, improving surgical outcomes for patients.
[Drug-resistant partial epilepsy. Invasive electrophysiological explorations].Isnard, J.[2006]

References

Recording local field potential and neuronal activity with tetrodes in epileptic patients. [2021]
A hybrid clinical-research depth electrode for acute and chronic in vivo microelectrode recording of human brain neurons. Technical note. [2006]
[Drug-resistant partial epilepsy. Invasive electrophysiological explorations]. [2006]
Subdural recording and electrical stimulation for cortical mapping and induction of usual seizures. [2018]
Development of high resolution, multiplexed electrode arrays: Opportunities and challenges. [2021]
Multipolar hollow-core electrode for brain recordings. [2019]
Safety profile of intracranial electrode implantation for video-EEG recordings in drug-resistant focal epilepsy. [2018]
First Food and Drug Administration Cleared Thin-Film Electrode for Intracranial Stimulation, Recording, and Monitoring of Brain Activity-Part 1: Biocompatibility Testing. [2022]
Clinical evaluation of a depth electroencephalography electrode. [2019]
A novel tetrode microdrive for simultaneous multi-neuron recording from different regions of primate brain. [2021]